Literature DB >> 20843831

The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome.

Daman Kumari1, Karen Usdin.   

Abstract

Fragile X syndrome (FXS) is the most common heritable cause of intellectual disability and the most common known cause of autism. Most cases of FXS result from the expansion of a CGG·CCG repeat in the 5' UTR of the FMR1 gene that leads to gene silencing. It has previously been shown that silenced alleles are associated with histone H3 dimethylated at lysine 9 (H3K9Me2) and H3 trimethylated at lysine 27 (H3K27Me3), modified histones typical of developmentally repressed genes. We show here that these alleles are also associated with elevated levels of histone H3 trimethylated at lysine 9 (H3K9Me3) and histone H4 trimethylated at lysine 20 (H4K20Me3). All four of these modified histones are present on exon 1 of silenced alleles at levels comparable to that seen on pericentric heterochromatin. The two groups of histone modifications show a different distribution on fragile X alleles: H3K9Me2 and H3K27Me3 have a broad distribution, whereas H3K9Me3 and H4K20Me3 have a more focal distribution with the highest level of these marks being present in the vicinity of the repeat. This suggests that the trigger for gene silencing may be local to the repeat itself and perhaps involves a mechanism similar to that involved in the formation of pericentric heterochromatin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843831      PMCID: PMC2972696          DOI: 10.1093/hmg/ddq394

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  68 in total

1.  The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.

Authors:  A C Bell; A G West; G Felsenfeld
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

2.  Gene structure and expression of the 5'-(CGG)(n)-3'-binding protein (CGGBP1).

Authors:  Frauke Naumann; Ralph Remus; Birgit Schmitz; Walter Doerfler
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

3.  The nucleation and maintenance of heterochromatin by a histone deacetylase in fission yeast.

Authors:  Takatomi Yamada; Wolfgang Fischle; Tomoyasu Sugiyama; C David Allis; Shiv I S Grewal
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

4.  The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications.

Authors:  Nele Gheldof; Tomoko M Tabuchi; Job Dekker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

5.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

Authors:  T A Comery; J B Harris; P J Willems; B A Oostra; S A Irwin; I J Weiler; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

7.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

8.  Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations.

Authors:  Elisabetta Tabolacci; Umberto Moscato; Francesca Zalfa; Claudia Bagni; Pietro Chiurazzi; Giovanni Neri
Journal:  Eur J Hum Genet       Date:  2008-07-16       Impact factor: 4.246

9.  The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter.

Authors:  Daman Kumari; Andrei Gabrielian; David Wheeler; Karen Usdin
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

10.  Fragile X (CGG)n repeats induce a transcriptional repression in cis upon a linked promoter: evidence for a chromatin mediated effect.

Authors:  Simon P Chandler; Pushpa Kansagra; Mark C Hirst
Journal:  BMC Mol Biol       Date:  2003-03-21       Impact factor: 2.946

View more
  40 in total

Review 1.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  Defining the role of the CGGBP1 protein in FMR1 gene expression.

Authors:  Martina Goracci; Stella Lanni; Giorgia Mancano; Federica Palumbo; Pietro Chiurazzi; Giovanni Neri; Elisabetta Tabolacci
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

3.  Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription.

Authors:  Daman Kumari; Karen Usdin
Journal:  Hum Mol Genet       Date:  2014-07-23       Impact factor: 6.150

Review 4.  Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia.

Authors:  Daman Kumari; Rachel Lokanga; Dmitry Yudkin; Xiao-Nan Zhao; Karen Usdin
Journal:  Biochim Biophys Acta       Date:  2012-01-05

5.  Size and methylation mosaicism in males with Fragile X syndrome.

Authors:  Poonnada Jiraanont; Madhur Kumar; Hiu-Tung Tang; Glenda Espinal; Paul J Hagerman; Randi J Hagerman; Nuanchan Chutabhakdikul; Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2017-11       Impact factor: 5.225

6.  Associations between post translational histone modifications, myelomeningocele risk, environmental arsenic exposure, and folate deficiency among participants in a case control study in Bangladesh.

Authors:  Jannah Tauheed; Marco Sanchez-Guerra; Jane J Lee; Ligi Paul; Md Omar Sharif Ibne Hasan; Quazi Quamruzzaman; Jacob Selhub; Robert O Wright; David C Christiani; Brent A Coull; Andrea A Baccarelli; Maitreyi Mazumdar
Journal:  Epigenetics       Date:  2017-04-07       Impact factor: 4.528

Review 7.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

Review 8.  RNA-mediated toxicity in neurodegenerative disease.

Authors:  Veronique V Belzil; Tania F Gendron; Leonard Petrucelli
Journal:  Mol Cell Neurosci       Date:  2012-12-29       Impact factor: 4.314

9.  Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27.

Authors:  Daman Kumari; Karen Usdin
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

Review 10.  Bidirectional transcription of trinucleotide repeats: roles for excision repair.

Authors:  Helen Budworth; Cynthia T McMurray
Journal:  DNA Repair (Amst)       Date:  2013-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.